Preventing infectious diseases with proven adjuvant technology

Committed to developing
novel vaccines

We are a commercial-stage biopharmaceutical company committed to developing and commercializing novel vaccines to help protect the world against infectious diseases, by utilizing proven, innovative adjuvant technology.

who we are

Make A Difference

Join a dynamic team dedicated to making a difference

Our mission and passion for what we do are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture.

Join Us

Empower

Recent News

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 12, 2025

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 07, 2025

/C O R R E C T I O N -- Dynavax Technologies/